Developing New Tests to Find and Defeat Cancer at Earliest Stages - Insights
Some early-stage cancers are missed by conventional screening and are only detected when symptoms occur. Mayo Clinic is collaborating with Grail, a life science company, and Sutter Health of California, on the STRIVE clinical research study...
New Eligibility Guidelines for Blood Donors with Previous Cancer Diagnoses - Insights
To coincide with American Red Cross recommendations, the Mayo Clinic Blood Donor Program has redefined eligibility guidelines for donors who have had a history of previous cancer diagnoses.
A new comprehensive genetic panel redefines Parkinson's disease diagnosis - Insights
Mayo Clinic Laboratories introduces the Inherited Parkinson’s Disease Gene Panel (Mayo ID: PARDP), a collaborative breakthrough poised to transform Parkinson’s disease diagnosis and treatment. Led by Rodolfo Savica, M.D., Ph.D., and Zhiyv...
Laboratory Testing for IBS in Clinical Laboratory News - Insights
Point-of-Care Testing at Mayo Clinic in Rochester, recently authored an article in Clinical Laboratory News on irritable bowel syndrome....
Ph.D., Weigh in on Opioids in Clinical Laboratory News - Insights
Department of Laboratory Medicine and Pathology, weigh in on opioid therapy in Clinical Laboratory News....
Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Mayo Clinic was named the best hospital in the nation in U.S. News & World Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties...
Scaling monkeypox testing and the new COVID variant: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with podcast host Bobbi...
Sickle cell disease: How new technologies are transforming patient lives - Insights
In this “Future Direction of Laboratory Medicine” webinar, Maggie DiGuardo, M.D., and Justin Juskewitch, M.D., Ph.D., will review the current knowledge regarding sickle cell disease from its genetic cause to the myriads of effects it can...
What's Next in Precision Medicine: Moving New Discoveries into Daily Clinical Care - Insights
Experts in individualized medicine—the concept of shaping health care based on lifestyle, environment, and genetic code—will be in Rochester September 12–13 to present how the newest discoveries can be applied to personalized health care.
Performed on cerebrospinal fluid, Mayo Clinic’s RT-QuIC prion test can distinguish prion disease from other types of rapidly progressive dementias to enhance patient care.